Immuno-oncology Drugs Market is expected to reach US$ 422.49Bn. at a CAGR of 23 during the forecast period 2029. Anticipated Growth in Revenue: Immuno-oncology Drugs Market, the artificial stimulation of the immune system to treat cancer, has emerged as a promising therapy in the fight against cancer. By enhancing the immune system's ability to combat the disease, immuno-oncology...